Lisa Conte

Lisa is founder and CEO of Napo Pharmaceuticals, which brings proprietary products to the global marketplace through local partnerships Lisa recently successfully completely the initial public offering of Napo on the London Stock Exchange—the first US company to do so. Napo embraces the” triple bottom line” goals of enhancing financial return by addressing global health needs in its development strategy and environmental sustainability in sourcing its lead product, which is harvested from rain forest areas. Prior to founding Napo, she founded Shaman Pharmaceuticals, Inc., a natural product pharmaceutical company, in 1989, which she also took public on NASDEQ. Lisa received her AB in Biochemistry from Dartmouth College, her MS in Physiology/Pharmacology from the University of California at San Diego and her MBA from the Amos Tuck School, Dartmouth College. She is the recipient of several entrepreneurship awards, including the 1994 E&Y Entrepreneur of the Year Award, and has sat on several industry boards.